EVHNYSEServices-Management ServicesFiscal year ends December 31
Evolent Health, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$4.48−0.09 (-1.97%)
Close on Oct 19, 2026
- Market cap
- $504.19M
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
Evolent Health has not reported a dividend
No dividend per share appears in Evolent Health's annual filings since fiscal 2012.